We need every state and county in the United States to vaccinate their citizens. But historical trends show that we should expect different challenges to getting shots in arms, depending on where people live. To increase vaccine coverage across communities, we can’t take a one-size-fits-all approach. The COVID-19 Vaccine Coverage Index (CVAC) can help. By drilling down to the county level, the CVAC shows precisely which barriers each U.S. community is likely to face in achieving high vaccine coverage and why, so we can develop targeted solutions to help them.
Depending on where you live, scale-up of COVID-19 vaccination may be more difficult. How concerned should you be?
The CVAC captures supply- and demand-related challenges that may hinder rapid, widespread COVID-19 vaccine coverage in U.S. counties, through five specific themes.
Full vaccination coverage rates have reached:
California
United States
This report introduces the CVAC and describes which U.S. communities—geographically and demographically—are at greatest risk of poor vaccination coverage. We also present the results of research pairing our CVAC data with the latest vaccine rollout numbers, as well as Google Trends data, showing how the presence of different barriers relate to people’s online searches for information about getting vaccinated
The COVID-19 Vaccine Coverage Index, launched by Surgo Ventures in February 2021, helps federal, state, and county decision makers identify which communities face challenges to vaccine coverage and why, based on the community-level barriers affecting COVID-19 vaccine uptake. The index captures 28 supply and demand factors through five different themes. The index’s modular design helps contextualize vaccine rollout performance and highlight inequities across communities—helping keep a pulse on the pace of efforts to ensure equitable, efficient vaccination.
Not all supply-and-demand side factors driving COVID-19 vaccine coverage are available at a granular level across geographies. The historic undervaccination theme accounts for these factors as an outcome, rather than an action-oriented barrier. While much remains unknown about how we will progress to widespread COVID-19 vaccination coverage, the index measures underlying community characteristics limiting coverage so that we can proactively address barriers based on current data. The index has been constructed using the best available data and will continue to be validated as granular vaccination administration data is shared publicly for all geographies. Get in touch to learn more about our methodology or access the data.